📖

Ceftriaxone for Amyotrophic Lateral Sclerosis

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-ceftriaxone-als

Related Entities

therapeutics-ceftriaxone-als

Metadata

slug	therapeutics-ceftriaxone-als
entity_type	therapeutic
kg_node_id	None

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (42)

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

mentions🧪APOE-Dependent Autophagy Restoration65%

related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides63%

mentions🔬What are the mechanisms underlying tdp-43 phase separation t60%

mentions🔬What are the mechanisms underlying rna binding protein dysre60%

mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%

mentions🔬Analyze the spectrum of microglial activation states (DAM, h60%

mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%

mentions🔬RNA binding protein dysregulation across ALS FTD AD60%

mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes60%

mentions🔬RNA binding protein dysregulation across ALS FTD and AD60%

see_also📖entities-gfap60%

related🧪APOE-Dependent Autophagy Restoration58%

related🔬What are the mechanisms underlying tdp-43 phase separation t54%

related🔬What are the mechanisms underlying rna binding protein dysre54%

related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%

related🔬Analyze the spectrum of microglial activation states (DAM, h54%

related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%

related🔬RNA binding protein dysregulation across ALS FTD AD54%

related🔬TDP-43 undergoes liquid-liquid phase separation that becomes54%

related🔬RNA binding protein dysregulation across ALS FTD and AD54%

mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧪APOE Isoform Conversion Therapy50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🧪APOE-Dependent Autophagy Restoration50%

mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi44%

mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau44%

mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and44%

mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring44%

mentions🧫iPSC-NPC effects on astrocytes in vitro ICH model44%

mentions🧫P2RY12-MTOR pathway interaction in VSMCs44%

mentions🧫iPSC-NPC transplantation in ICH animal model44%

mentions🔬What are the mechanisms underlying blood-brain barrier trans40%